Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.140 (-5.51%)
At close: Dec 5, 2025, 4:00 PM EST
2.440
+0.040 (1.67%)
After-hours: Dec 5, 2025, 7:20 PM EST
CNTB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -49.28 | -15.63 | -62.11 | -118.09 | -202.27 | -119.36 | Upgrade
|
| Depreciation & Amortization | 0.68 | 0.66 | 0.72 | 1.03 | 0.63 | 0.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.01 | 0.1 | - | 0.04 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.23 | 0.23 | - | 4.7 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.73 | -0.12 | -1.7 | - | - | - | Upgrade
|
| Stock-Based Compensation | 4.21 | 6.73 | 5.4 | 6.91 | 8.99 | 3.86 | Upgrade
|
| Other Operating Activities | - | - | - | -2.52 | 104.7 | 90.11 | Upgrade
|
| Change in Accounts Receivable | 5 | -0.79 | - | 4.05 | -2.31 | -1.43 | Upgrade
|
| Change in Accounts Payable | 1.61 | -1.87 | -1.14 | -0.78 | 8.97 | 0.28 | Upgrade
|
| Change in Unearned Revenue | -0 | -13.16 | 13.32 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -4.04 | 0.32 | -2.33 | 3.19 | -3.08 | 0.71 | Upgrade
|
| Operating Cash Flow | -42.28 | -23.61 | -47.74 | -101.52 | -84.32 | -25.6 | Upgrade
|
| Capital Expenditures | -0.73 | -0.75 | -0.08 | -4.41 | -3.83 | -2.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | 0 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | 2.94 | - | -0.05 | -0.05 | Upgrade
|
| Investment in Securities | -16.2 | -2.7 | 72.12 | -81.84 | 2.12 | 2.79 | Upgrade
|
| Other Investing Activities | - | - | - | - | -3.44 | - | Upgrade
|
| Investing Cash Flow | -16.93 | -3.45 | 74.98 | -86.24 | -5.21 | 0.45 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.22 | -0.13 | -0.08 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.22 | -0.13 | -0.08 | Upgrade
|
| Issuance of Common Stock | 0.48 | 0.23 | 0.05 | 0.14 | 220.02 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.57 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -17.11 | -0.6 | Upgrade
|
| Financing Cash Flow | 0.48 | 0.23 | 0.05 | -0.09 | 202.22 | 140.73 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.63 | -0.6 | -0.57 | -0.86 | 0.22 | -8.18 | Upgrade
|
| Net Cash Flow | -59.35 | -27.43 | 26.72 | -188.71 | 112.91 | 107.39 | Upgrade
|
| Free Cash Flow | -43.01 | -24.36 | -47.82 | -105.93 | -88.16 | -27.9 | Upgrade
|
| Free Cash Flow Margin | -5643.83% | -93.58% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.78 | -0.44 | -0.87 | -1.92 | -1.69 | -1.63 | Upgrade
|
| Cash Income Tax Paid | 0.12 | 0.11 | 0.12 | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -23.1 | -25.55 | -67.55 | -46.03 | -16.98 | Upgrade
|
| Unlevered Free Cash Flow | - | -23.1 | -25.55 | -67.54 | -46.02 | -16.7 | Upgrade
|
| Change in Working Capital | 2.57 | -15.49 | 9.85 | 6.46 | 3.58 | -0.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.